Autolus Therapeutics (AUTL) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to -$367.4 million.
- Autolus Therapeutics' Enterprise Value rose 4420.6% to -$367.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$367.4 million, marking a year-over-year increase of 4420.6%. This contributed to the annual value of -$588.0 million for FY2024, which is 14466.81% down from last year.
- Autolus Therapeutics' Enterprise Value amounted to -$367.4 million in Q3 2025, which was up 4420.6% from -$454.3 million recorded in Q2 2025.
- Autolus Therapeutics' 5-year Enterprise Value high stood at -$163.4 million for Q3 2022, and its period low was -$759.5 million during Q1 2024.
- Its 5-year average for Enterprise Value is -$377.5 million, with a median of -$310.7 million in 2021.
- Per our database at Business Quant, Autolus Therapeutics' Enterprise Value plummeted by 3942620.87% in 2021 and then soared by 4420.6% in 2025.
- Over the past 5 years, Autolus Therapeutics' Enterprise Value (Quarter) stood at -$310.7 million in 2021, then decreased by 23.2% to -$382.8 million in 2022, then soared by 37.21% to -$240.3 million in 2023, then tumbled by 144.67% to -$588.0 million in 2024, then surged by 37.52% to -$367.4 million in 2025.
- Its last three reported values are -$367.4 million in Q3 2025, -$454.3 million for Q2 2025, and -$516.6 million during Q1 2025.